173 related articles for article (PubMed ID: 23446204)
1. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM
J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of
Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G
Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114
[TBL] [Abstract][Full Text] [Related]
4. Impact of
Akamine T; Nakagawa K; Ito K; Watanabe H; Yotsukura M; Yoshida Y; Yatabe Y; Kusumoto M; Watanabe SI
Ann Surg Oncol; 2024 Jan; 31(1):192-200. PubMed ID: 37743455
[TBL] [Abstract][Full Text] [Related]
5. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours.
Ying J; Huang Y; Ye X; Zhang Y; Yao Q; Wang J; Yang X; Yu C; Guo Y; Zhang X; Lv Q; Wang C; Mao W; Zhao A
Int Immunopharmacol; 2024 Jan; 126():111205. PubMed ID: 38029550
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of PET/CT Fluorodeoxyglucose inclusion on mortality and survival in operated thymoma patients.
Agaoglu Sanli B; Duman E; Gulmez B; Aguloglu N; Yazgan S; Ceylan KC; Ucvet A
Nucl Med Commun; 2024 Mar; 45(3):236-243. PubMed ID: 38165166
[TBL] [Abstract][Full Text] [Related]
8. Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.
Khoury T; Chandrasekhar R; Wilding G; Tan D; Cheney RT
Int J Exp Pathol; 2011 Apr; 92(2):87-96. PubMed ID: 21044186
[TBL] [Abstract][Full Text] [Related]
9. Thymic Imaging Pitfalls and Strategies for Optimized Diagnosis.
Klug M; Strange CD; Truong MT; Kirshenboim Z; Ofek E; Konen E; Marom EM
Radiographics; 2024 May; 44(5):e230091. PubMed ID: 38602866
[TBL] [Abstract][Full Text] [Related]
10. The Role of [
Civan C; Ozkan ZG; Ozkan B; Isik EG; Erdogdu E; Has Simsek D; Duman S; Sanli Y; Kara M; Kuyumcu S; Toker A
Cancer Biother Radiopharm; 2024 Mar; ():. PubMed ID: 38484307
[No Abstract] [Full Text] [Related]
11. Quantitative CT parameters combined with preoperative systemic inflammatory markers for differentiating risk subgroups of thymic epithelial tumors.
Gao R; Zhou J; Zhang J; Zhu J; Wang T; Yan C
BMC Cancer; 2023 Nov; 23(1):1158. PubMed ID: 38012604
[TBL] [Abstract][Full Text] [Related]
12. Thymic epithelial tumor treatment in Japan: analysis of hospital cancer registry and insurance claims data, 2012-2014.
Kanemura H; Tamura T; Nishimura N; Kobayashi D; Higashi T
Jpn J Clin Oncol; 2020 Mar; 50(3):310-317. PubMed ID: 31829410
[TBL] [Abstract][Full Text] [Related]
13. Dual-energy CT perfusion imaging for differentiating WHO subtypes of thymic epithelial tumors.
Yu C; Li T; Zhang R; Yang X; Yang Z; Xin L; Zhao Z
Sci Rep; 2020 Mar; 10(1):5511. PubMed ID: 32218504
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effectiveness of chemotherapy for thymic epithelial tumors using the CD-DST method.
Yu L; Zhang BX; Du X; Yu Z; Yang XG; Jiang YX
Thorac Cancer; 2020 May; 11(5):1160-1169. PubMed ID: 32196982
[TBL] [Abstract][Full Text] [Related]
15. The maximal contrast-enhanced range of CT for differentiating the WHO pathological subtypes and risk subgroups of thymic epithelial tumors.
Yu C; Li T; Yang X; Xin L; Zhao Z; Yang Z; Zhang R
Br J Radiol; 2023 Oct; 96(1150):20221076. PubMed ID: 37486626
[TBL] [Abstract][Full Text] [Related]
16. Thymic carcinoid mimicking mediastinal lymphoma on
Liu H; Liu L; Chen Y
J Nucl Cardiol; 2021 Jun; 28(3):1193-1195. PubMed ID: 32236838
[No Abstract] [Full Text] [Related]
17. Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors.
Giaccone G; Rajan A; Berman A; Kelly RJ; Szabo E; Lopez-Chavez A; Trepel J; Lee MJ; Cao L; Espinoza-Delgado I; Spittler J; Loehrer PJ
J Clin Oncol; 2011 May; 29(15):2052-9. PubMed ID: 21502553
[TBL] [Abstract][Full Text] [Related]
18. [Clinical diagnosis and treatment analysis of 21 cases of intrathyroid thymic carcinoma].
Feng GC; Liu Z; Li HQ; Zuo DH; Sun HL; Qiao LX; Yin DT
Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(6):440-444. PubMed ID: 38326056
[No Abstract] [Full Text] [Related]
19. Locally advanced thymoma; does neoadjuvant chemotherapy make a difference?
Abdel Jalil R; Abdallah FA; Obeid Z; Harb AK; Abou Chaar MK; Shannies TB; El-Edwan A; Haddad H; Ghraibeh A; Abu-Shanab A
J Cardiothorac Surg; 2023 Aug; 18(1):245. PubMed ID: 37592291
[TBL] [Abstract][Full Text] [Related]
20. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
